Research programme: glycogen synthase kinase 3 inhibitors - CrystalGenomics
Alternative Names: CG-9Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator CrystalGenomics
- Class
- Mechanism of Action Glycogen synthase kinase 3 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer